- Consumable
- Instruments
- Others
DNA Sequencing Market size was valued at USD 10.7 billion in 2023 and is expected to grow at a CAGR of 12.2% from 2024 - 2030. the forecast period. The sequences of the bases {adenine (A), cytosine (C), guanine (G), and thymine (T)} in a DNA molecule can be ascertained by a laboratory procedure called DNA sequencing. The DNA that needs to be sequenced is prepared in a sample. The polymerase chain reaction (PCR) is subsequently used to amplify the target sequence. The amplicons are then carefully purified, and the DNA sequencing procedures are initiated. After the DNA is sequenced, the necessary data is obtained and examined.
The National Human Genome Research Institute (NHGRI) has announced that the genetic makeup of all humans is 99.9% the same. DNA sequencing is used to investigate the remaining 0.1% to identify the disorders' underlying causes. Numerous fields, including molecular biology, evolutionary biology, metagenomics, virology, medicine, and forensic investigations, have found extensive uses for this technique. the continuous evolution of genome sequencing technology has revolutionized the genomics field and is widespread across the healthcare industry.
Moreover, technological advancements have resulted in sizeable improvements in sequencing speed. these platforms employ parallel processing enabling the simultaneous analysis of multiple DNA fragments. This acceleration in speed has far-reaching implications, allowing researchers and clinicians to process large volumes of genomic data more efficiently than ever. For instance, in March 2023 Illumina, Inc. unveiled its connected insights base software designed to facilitate tertiary analysis for clinical NGS data. Such initiatives are expected to drive the market growth in forecasting years. Overall technological advancement continues to straighten out the complexity of the human genome, Researchers, and health care professionals are increasingly turning to DNA sequencing to obtain valuable insights that have transformative implications for medical diagnosis, treatment, and disease prevention.
Study Period
2024 - 2030Base Year
2023CAGR
12.2%Largest Market
North AmericaFastest Growing Market
North America
Market stage growth is high and the pace of the market growth is accelerating. The market is segmented by a high degree of innovation due to the rapid advancement of technology like the adoption of artificial intelligence and machine learning in the genome. By adoption of AI and cloud computing is expected to bring novel products and services across the market. The growing actability of reagents and kits used for various construction stages including DNA fragmentation, adaptor ligation, and quality control is a key factor in expanding market shares. The academic research held the market in 2023 with the largest revenue shares. Thus, this can be attributed to the wide acceptability of Sanger technology and NGS in academic and institutional research projects. Collaborations between public and private entities can expand access to the DNA sequencing market. Moreover, the implementation of DNA analysis for studying tumor heterogeneity, the discovery of new cancer-related genes, and the identification of alteration related to tumorigenesis are expected to result in significant growth of this segment.
By Product Type
By Sequencing Type
By End User
The dna sequencing market was valued at USD 10.7 billion in 2023 and is expected to grow at a CAGR of 12.2% over the forecast period.
The DNA sequencing market includes technological advancements in sequencing techniques, rising interest in genomics and personalized medicine, and increasing applications of DNA sequencing in clinical diagnostics. These are the driving factors of the DNA sequencing market.
The next-generation sequencing type holds the maximum share of the technology market.
The Asian Pacific region is the fastest-growing region in the DNA sequencing market.
Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Myriad Genetics, QIAGEN, Neo tech.
1. Executive Summary |
2. Global DNA Sequencing Market Introduction |
2.1.Global DNA Sequencing Market - Taxonomy |
2.2.Global DNA Sequencing Market - Definitions |
2.2.1.Product Type |
2.2.2.Sequencing Type |
2.2.3.End Users |
2.2.4.Region |
3. Global DNA Sequencing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global DNA Sequencing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global DNA Sequencing Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Consumable |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Instruments |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global DNA Sequencing Market By Sequencing Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Sanger sequencing |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Next generation sequencing |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global DNA Sequencing Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Academic Research |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Clinical research |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Clinics |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global DNA Sequencing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America DNA Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Consumable |
9.1.2.Instruments |
9.1.3.Others |
9.2. Sequencing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Sanger sequencing |
9.2.2.Next generation sequencing |
9.2.3.Others |
9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Academic Research |
9.3.3.Clinical research |
9.3.4.Clinics |
9.3.5.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe DNA Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Consumable |
10.1.2.Instruments |
10.1.3.Others |
10.2. Sequencing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Sanger sequencing |
10.2.2.Next generation sequencing |
10.2.3.Others |
10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Academic Research |
10.3.3.Clinical research |
10.3.4.Clinics |
10.3.5.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) DNA Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Consumable |
11.1.2.Instruments |
11.1.3.Others |
11.2. Sequencing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Sanger sequencing |
11.2.2.Next generation sequencing |
11.2.3.Others |
11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Academic Research |
11.3.3.Clinical research |
11.3.4.Clinics |
11.3.5.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) DNA Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Consumable |
12.1.2.Instruments |
12.1.3.Others |
12.2. Sequencing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Sanger sequencing |
12.2.2.Next generation sequencing |
12.2.3.Others |
12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Academic Research |
12.3.3.Clinical research |
12.3.4.Clinics |
12.3.5.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America DNA Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Consumable |
13.1.2.Instruments |
13.1.3.Others |
13.2. Sequencing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Sanger sequencing |
13.2.2.Next generation sequencing |
13.2.3.Others |
13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Academic Research |
13.3.3.Clinical research |
13.3.4.Clinics |
13.3.5.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Illumina, Inc. |
14.2.2.Thermo Fisher Scientific, Inc. |
14.2.3.Pacific Biosciences. |
14.2.4.Agilent Technologies, Inc. |
14.2.5.Bio-Rad Laboratories, Inc. |
14.2.6.Myriad Genetics |
14.2.7.QIAGEN |
14.2.8.Neo tech |
14.2.9.Gilson |
14.2.10.Element Bioscience, Inc. |
15. Research Methodology |
16. Appendix and Abbreviations |